Consider it GmbH Revenue and Competitors
Estimated Revenue & Valuation
- Consider it GmbH's estimated annual revenue is currently $6.9M per year.
- Consider it GmbH's estimated revenue per employee is $117,000
Employee Data
- Consider it GmbH has 59 Employees.
- Consider it GmbH grew their employee count by 5% last year.
Consider it GmbH Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1.7M | 26 | -4% | $15.7M | N/A |
#2 | $1.4M | 21 | -50% | $21.2M | N/A |
#3 | $41.9M | 293 | 8% | $6M | N/A |
#4 | $6M | 53 | -22% | $216.8M | N/A |
#5 | $0M | 2 | 0% | $33.3M | N/A |
#6 | $26M | 182 | 0% | N/A | N/A |
#7 | $30.9M | 221 | -26% | $64.6M | N/A |
#8 | $28.6M | 205 | -22% | $46.8M | N/A |
#9 | $249.1M | 1340 | 15% | $75M | N/A |
#10 | $12.4M | 95 | 3% | N/A | N/A |
What Is Consider it GmbH?
FÜR TALENTE Wir verfügen über innovatives Know-How aus unseren eigenen Projekten, wir kennen den TECH-Bereich und wir sagen: The candidate is the boss FÜR UNTERNEHMEN Wir sind vernetzt, wir haben die neuesten Technologien zur Hand, wir sind authentisch. Jede Vermittlung ist uns ein persönliches Anliegen.
keywords:N/A
N/A
Total Funding
59
Number of Employees
$6.9M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Consider it GmbH News
By Jochen Kern, head of sales & marketing, micrometal GmbH ... the field is narrowed, and most people consider that the viable alternatives...
In 2016, German biotech company JeNaCell GmbH devised means for large-scale production of biosynthetic cellulose and brought it to market...
Genevant Sciences GmbH et al. ... In the last few years, it has not grown its head count substantially, nor has it increased its market...
Other Companies in Hamburg
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.7M | 59 | -14% | N/A |
#2 | N/A | 59 | 69% | N/A |
#3 | $11.5M | 61 | -10% | N/A |
#4 | $8.1M | 62 | 19% | N/A |
#5 | N/A | 62 | 24% | N/A |